Iodine-Based Coordination Compounds: A Strategy Toward Antibiotic Potentiation
Authors:
- Daniil ShepilovDaniil Shepilov
- Dana AskarovaDADana Askarova
- Anar SeisembekovaASAnar Seisembekova
- Seitzhan TurganbaySTSeitzhan Turganbay
- Ardak JumagaziyevaAJArdak Jumagaziyeva
- Tamara BukeyevaTBTamara Bukeyeva
- Gulnara YuldashevaGYGulnara Yuldasheva
- Nurdaulet TemirNTNurdaulet Temir
- Lyudmila IvanovaLILyudmila Ivanova
- Natalya ZubenkoNZNatalya Zubenko
- Sabina KeneshevaSKSabina Kenesheva
Preprint
- 15 April 2026
- preprint
- Published by MDPI AG in Preprints.org
Abstract
Due to the increasing threat of antibiotic resistance and the emergence of new pathogenic strains, the development of effective combined therapeutic agents represents a crucial direction in the fight against infections. Within this study, several compounds were synthesized in which iodine is present in a coordination complex with antibiotics – sodium sulfathimidine and gentamicin sulfate. The physicochemical parameters of these compounds were investigated using capillary electrophoresis and UV-spectroscopy, along with their cytotoxicity, antimicrobial, and antiviral activities. As a result of this work, two stable compounds, KC-246 and KC-248, were synthesized, demonstrating virus-inhibitory activity against herpes simplex virus and influenza A under extremely low cytotoxicity levels of 0.018–0.106 mg/ml. Additionally, they exhibited antimicrobial activity against representatives of the families Staphylococcaceae, Pseudomonadaceae, Enterobacteriaceae, Enterococcaceae, and yeast-like fungi. The minimum bactericidal concentrations (MBCs) ranged from 0.794 µg/ml to 0.198 µg/ml (KC-246) and from 2.093 µg/ml to 0.523 µg/ml (KC-248).Keywords
All Related Versions
This publication has 15 references indexed in Scilit:
- Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050The Lancet, 2024
- Clinical Pharmacokinetics of Gentamicin in Various Patient Populations and Consequences for Optimal Dosing for Gram-Negative Infections: An Updated ReviewClinical Pharmacokinetics, 2022
- Advancing Diagnostic Stewardship for Healthcare-Associated Infections, Antibiotic Resistance, and SepsisClinical Infectious Diseases, 2021
- Methods for in vitro evaluating antimicrobial activity: A reviewJournal of Pharmaceutical Analysis, 2016
- Mechanisms of resistance to aminoglycoside antibiotics: overview and perspectivesMedChemComm, 2015
- Halogen Interactions in Protein–Ligand Complexes: Implications of Halogen Bonding for Rational Drug DesignJournal of Chemical Information and Modeling, 2013
- Antimicrobial Drugs2006
- Colistin: The Revival of Polymyxins for the Management of Multidrug-Resistant Gram-Negative Bacterial InfectionsClinical Infectious Diseases, 2005
- Pharmaceuticals2004
- Determination of minimum inhibitory concentrationsJournal of Antimicrobial Chemotherapy, 2001